Innovation Pharmaceuticals Inc (IPIX)

[Stockstuffer83]

The most interesting thing about the hater article today by the street was he kept saying that the company is hiding trail data failure and lumping all doses together to show treatment success BUT that is not the point of a phase two trial.

Per the FDA website

Phase 2

Patients: Up to several hundred people with the disease/condition.
Length of Study: Several months to 2 years

Purpose: Efficacy and side effects
In Phase 2 studies, researchers administer the drug to a group of patients with the disease or condition for which the drug is being developed. Typically involving a few hundred patients, these studies aren't large enough to show whether the drug will be beneficial.